contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


asker-healthcare-group-ab-interim-report-1-january-31-march-2025

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Asker Healthcare is a serial acquirer within medical technology products and services. The group consists of a number of companies with operations in several countries in Europe. Through the company's growth platform, they continuously acquire medtech companies in the European market, with the goal of improving healthcare outcomes and supporting the healthcare sector. The company is headquartered in Danderyd.

Asker Healthcare

Steady quarter of profitable growth Net sales amounted to SEK 3,995m (3,455), up 16 percent. Adjusted EBITA amounted to SEK 364m (312), up 17 percent, and the adjusted EBITA margin amounted ...

<h2>Steady quarter of profitable growth</h2><ul>	<li>Net sales amounted to SEK 3,995m (3,455), up 16 percent. </li>	<li>Adjusted EBITA amounted to SEK 364m (312), up 17 percent, and the adjusted EBITA margin amounted to 9.1 percent (9.0). </li>	<li>EBIT amounted to SEK 237m (196) and the profit amounted to SEK 95m (69). </li>	<li>Earnings per share before and after dilution amounted to SEK 0.19 (0.12). </li>	<li>Return on net working capital (EBITA/NWC) amounted to 66.5 percent (63.7).</li>	<li>Cash flow from operating activities amounted to SEK 109m (237). </li>	<li>In February, Asker completed two acquisitions: Hospital Services Limited in Ireland and the UK, and Mayumana Healthcare in the Netherlands. </li>	<li>On 27 March, Asker Healthcare Group AB was listed on Nasdaq Stockholm Large Cap.</li></ul>CEO Johan Falk comments on the quarter"Continued steady and profitable growth driven by organic initiatives and strategic acquisitions that have broadened our customer offering and provided access to more markets. The listing on Nasdaq Stockholm in March marks a major milestone."For the full CEO comment, please see the interim report.Presentation of the interim reportThe interim report will be presented today, May 13, at 10:00 CEST by Asker's CEO Johan Falk and CFO Thomas Moss. You will find the webcast via <a href="https://asker-healthcare.events.inderes.com/q1-report-2025/register">this link</a>. To participate via phone and ask questions, please register via <a href="https://conference.inderes.com/teleconference/?id=5003678">this link</a>.For further information, please contact: Thomas Moss, CFO and Head of Investor Relations Phone: +46 70 219 79 05, E-mail: <a href="mailto:ir@asker.com">ir@asker.com</a>Emma Rheborg, Head of Communication Phone: +46 73 313 62 17, E-mail: <a href="mailto:emma.rheborg@asker.com">emma.rheborg@asker.com</a>Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group - driving progress in the healthcare sector. The group has more than 4 000 employees in 17 countries and revenues amounting to SEK 16 billion.The information was submitted for publication, through the agency of the contact person set out above, at 08:10 CEST on May 13, 2025.<div></div>